Subscribe to Cardiovascular
View Sample

FREE Email Newsletter

American Regent Initiates Voluntary Nationwide Recall of Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial Due to Particulates

June 15, 2011 12:32 pm | by Bio-Medicine.Org | News | Comments

SHIRLEY, N.Y., June 15, 2011 /- American Regent is conducting a voluntary nationwide recall to the user and consumer level of the following product: Concentrated Sodium Chloride Injection, USP, 23.4%, 30 mL Single Dose Vial, Lot # 0362, Expiration Date: May 2012, NDC # 0517-2930-25 PL...

Cordis Announces Discontinuation of NEVOâ„¢ Sirolimus-Eluting Coronary Stent

June 15, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BRIDGEWATER, N.J., June 15, 2011 /- Cordis Corporation, a worldwide leader in the development and manufacture of interventional vascular technology, today announced it will no longer pursue the development of the NEVO™ Sirolimus-Eluting Coronary Stent in order to focus on other...

B. Braun Medical Inc. Named Best Company to Work For

June 15, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

BETHLEHEM, Pa., June 15, 2011 /- B. Braun Medical Inc. (B. Braun) is part of one of the fastest growing medical technology corporations in the world -- it's also one of the Best Companies to Work For , according to Medical Device and Diagnostic Industry (MD+DI) magazine. One of just 10...


Masimo Announces Rainbow Agreement with Philips

June 15, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif., June 15, 2011 /- Masimo (NASDAQ: MASI ) today announced that it has reached a long-term non-exclusive agreement under which Philips will integrate Masimo rainbow SET® technology into Philips' products.  Masimo expects to begin diligent co-development projects...

Dr. F. John Mills Joins Intelsius' Board of Directors as Non-Executive Chair

June 15, 2011 5:34 am | by Bio-Medicine.Org | News | Comments

YORK, England, June 15, 2011 /- Intelsius, a global manufacturer and distributor of environmentally safe, temperature-controlled and regulatory-compliant packaging solutions, announced today that it has appointed Dr. F. John Mills, M.D., Ph.D., to the company's board of directors as...

Flexible Endoscope Manufacturer Determines Test Suitable for Evaluating Cleanliness of Flexible Endoscopes

June 14, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

FRASER, Mich., June 14, 2011 /- At the 2011 Society of Gastroenterology Nurses and Associates (SGNA) Convention held in Indianapolis, IN, Olympus America, Inc. (Allentown, PA) presented the results of a study evaluating the effectiveness of a 3-1 test strip for detecting residual organic...

Cardinal Health Extends Radiopharmaceutical Manufacturing Network, Opening its First Cyclotron in Georgia

June 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

AUGUSTA, Ga., June 14, 2011 /- Cardinal Health today opened its first cyclotron facility in the state of Georgia, further expanding its nationwide capability to manufacture molecular imaging biomarkers that aid in the early diagnosis, monitoring and treatment of cancer, neurological...

Lilly for Better Healthâ„¢ Launches Enhanced Multi-Channel Patient Education Platform

June 14, 2011 6:34 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 14, 2011 /- Lilly for Better Health ™, a program of Lilly USA, LLC, (NYSE: LLY ) that helps Americans live healthier, more active lives, launches an enhanced multi-channel platform designed to reach patients where they like to receive health information. The...


Low-Carbohydrate, High-Protein Diets May Reduce Both Tumor Growth Rates and Cancer Risk

June 14, 2011 6:33 am | by AACR | News | Comments

Tweet   • Laboratory study has clear implications for humans. • Low carbohydrates reduce blood glucose, which tumor cells need.• Possible anti-inflammatory effect also observed. PHILADELPHIA — Eating a low-carbohydrate, high-protein diet...

Vinomis Laboratories Launches Vindurance Challenge to Substantiate Claims of Enhanced Physical Endurance with Use of Resveratrol and Quercetin

June 14, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

SEWICKLEY, Pa., June 14, 2011 /- The benefits of resveratrol are well studied and documented in controlled scientific studies.  It has been shown to slow down the aging process and help prevent age-related diseases including heart disease, cancer, Alzheimer's, diabetes, and others....

Hotspur Technologies Appoints Fred Khosravi Chairman of the Board

June 14, 2011 4:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 14, 2011 /- Hotspur Technologies, a leading developer of catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels, today announced the appointment of Fred Khosravi to the newly-created position of Chairman of its Board of...

Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH Announce Positive Data in Portal Hypertension With Udenafil

June 13, 2011 8:34 am | by Bio-Medicine.Org | News | Comments

SEOUL, South Korea, June 13, 2011 /- Dong-A PharmTech Co., Ltd. and Dr. Falk Pharma GmbH announced positive results from an initial safety and efficacy portal hypertension study in man using udenafil, its new long-active phosphodiesterase inhibitor. The data was presented by the principal...

HDMA Honors Lupin with DIANA Award for Best Overall Generic Manufacturer

June 13, 2011 8:33 am | by Bio-Medicine.Org | News | Comments

MUMBAI, India, June 13, 2011 /- Pharma Major Lupin Limited announced today that its U.S. subsidiary, Lupin Pharmaceutical Inc. was presented with the 2011 DIANA Award by the Healthcare Distribution Management Association (HDMA) for the Best Overall Generic Product Manufacturer among those...


AACR Mourns the Loss of Laura Ziskin, Co-founder of SU2C

June 13, 2011 7:34 am | by AACR | News | Comments

Tweet   PHILADELPHIA - It is with immense sorrow and deep regret that we share the news of the passing of Laura Ziskin, co-founder of Stand Up To Cancer (SU2C). She was a staunch advocate of the value of cancer research in saving lives, and was a beloved friend and member of our AACR...

PerkinElmer buys X-ray tech firm Dexela

June 13, 2011 7:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

Waltham-based PerkinElmer Inc., a scientific instruments and services company, has acquired London-based Dexela Limited, a provider of X-ray detection technologies and services.

Stand Up To Cancer Co-Founder Laura Ziskin Dies at 61

June 13, 2011 6:32 am | by AACR | News | Comments

Los Angeles, CA – Acclaimed film producer and cancer activist Laura Ziskin died today at her home in Santa Monica at the age of 61. Ziskin, who lived with breast cancer for seven years, is survived by her husband, screenwriter Alvin Sargent, with whom she frequently collaborated;...

Thoratec Announces Resignation of Chief Financial Officer

June 10, 2011 12:33 pm | by Bio-Medicine.Org | News | Comments

PLEASANTON, Calif., June 10, 2011 /- Thoratec Corporation (NASDAQ: THOR ), a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts, announced today that David V. Smith, Executive Vice President and Chief Financial Officer, has...

BD and Heart to Heart International Launch Volunteer Service Trip to Help "Build Back Better" in Haiti

June 9, 2011 9:35 am | by Bio-Medicine.Org | News | Comments

FRANKLIN LAKES, N.J. and OLATHE, Kan., June 9, 2011 /- BD (Becton, Dickinson and Company) (NYSE: BDX ), a leading global medical technology company, and Heart to Heart International, a humanitarian medical aid nonprofit organization, announced a joint volunteer initiative to strengthen...

ChromaDex Licenses Additional Technology for pTeroPure® From the University of Mississippi

June 9, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

IRVINE, Calif. and OXFORD, Miss., June 9, 2011 /- ChromaDex Corp. (OTCBB: CDXC) and the University of Mississippi today announced the university has granted the natural products company the exclusive worldwide patent rights to a potential new therapeutic use for pterostilbene...

European Bioinformatics Institute Drives Genomics Research With GÉANT

June 9, 2011 4:32 am | by RealWire | News | Comments

High-speed GÉANT and JANET research networks enable global collaboration on 1000 Genomes ProjectCambridge, UK, June 9 2011 - The European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI), which hosts the world's largest public collection of molecular...

Wuzhou Changlian Introduces New Thermometer Series

June 8, 2011 11:32 am | by Bio-Medicine.Org | News | Comments

SHENZHEN, China, June 8, 2011 /PRNewswire-Asia/ -- To thank customers for their continuous support of our health care products including infrared thermometers , heart beat watches, blood pressure monitors and so on, Shenzhen Wuzhou Changlian International Trading Co. has decided to offer...

FDA Approves Updates to Lilly's Humalog® (insulin lispro injection rDNA origin) Label

June 8, 2011 5:33 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 8, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that the U.S. Food and Drug Administration (FDA) approved the company's supplemental new drug application (sNDA) with the following updates to the Humalog label: continuous insulin infusion pump therapy in...

iPS Academia Japan, Inc. to Distribute Cellular Dynamics' iCell® Products in Japan

June 8, 2011 3:34 am | by Bio-Medicine.Org | News | Comments

MADISON, Wis., June 8, 2011 /- Cellular Dynamics International, Inc. (CDI) today announced an agreement with iPS Academia Japan, Inc ., who will distribute CDI's iCell® Cardiomyocytes , the first commercially available product based on induced pluripotent stem cells (iPSCs), in...

Reportlinker Adds Asia-Pacific Markets for Patient Monitoring Devices 2011

June 8, 2011 2:33 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 8, 2011 /- announces that a new market research report is available in its catalogue: Asia-Pacific Markets for Patient Monitoring Devices 2011...

VEGF Trap-Eye Submitted for EU Marketing Authorization for Treatment of Wet Age-Related Macular Degeneration

June 6, 2011 11:33 pm | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y. and BERLIN, June 7, 2011 /- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN ) and Bayer HealthCare today announced that Bayer HealthCare has submitted an application for marketing authorization in Europe for VEGF Trap-Eye for the treatment of the neovascular form of...

You may login with either your assigned username or your e-mail address.
The password field is case sensitive.